Crossref

1. Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis

- Chaobin He

- Yu Zhang

- Xiaojun Lin

2. p53 gene therapy‐based transarterial chemoembolization for unresectable hepatocellular carcinoma: A prospective cohort study

- Ai Shen

- Shihong Liu

- Weiqian Yu

- Hejun Deng

- Qingdong Li

3. Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study

- Chao-Bin He

- Xiang-Ming Lao

- Xiao-Jun Lin